ClinicalTrials.gov
ClinicalTrials.gov Menu

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia (CEASE-VT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01097330
Recruitment Status : Terminated (Anticipated non-feasibility of recruitment objectives)
First Posted : April 1, 2010
Last Update Posted : August 5, 2011
Sponsor:
Collaborators:
Abbott Medical Devices
Hamilton Health Sciences Corporation
Information provided by:
Population Health Research Institute

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Estimated Primary Completion Date : August 2014
  Estimated Study Completion Date : December 2014

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 30, 2015
February 2, 2016